The trial was evaluating HyBryte in a rare form of cancer with limited treatment options. ・The company also plans to assess ...

Evidence suggests a greater prevalence of fibromyalgia among people with Behçet's disease than in the general population. Just as fibromyalgia appears to be more prevalent among women than men in the ...

Please provide your email address to receive an email when new articles are posted on . Week-22 remission rates were 81% among patients using infliximab and 56% in those on cyclophosphamide. Mild to ...

The monoclonal antibody ustekinumab (Stelara), which targets interleukin (IL)-12 and IL-23, appeared to be effective for clearing oral ulcers in Behcet's disease in a multicenter open-label study ...

Desbois and colleagues evaluated factors associated with relapse of thrombosis and mortality in patients with Behçet disease by performing chart reviews of 807 patients, 296 (37%) of whom had a total ...

What Is Behcet’s Syndrome? Behcet’s syndrome (also called Behcet’s disease) is rare condition that causes your body’s blood vessels to swell. This can cause symptoms throughout your body. Sores inside ...

A Bengaluru teenager has successfully undergone a rare surgery to repair a life-threatening aortic aneurysm caused by ...

SAN DIEGO — Apremilast quickly relieves painful oral and genital ulcers in patients with Behçet's disease and improves quality of life, compared with placebo, results of a phase 2 study suggest. "The ...

Soligenix is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need. Our Specialized BioTherapeutics ...

Please provide your email address to receive an email when new articles are posted on . The rare and complex Behcet’s disease is often misdiagnosed or undiagnosed, leading to significant, but ...

The small-molecule phosphodiesterase 4 inhibitor apremilast modulates cytokines that are up-regulated in Behçet’s syndrome. In a phase 2 trial involving patients with Behçet’s syndrome, apremilast ...